Company Information

NOVARTIS INDIA LTD.

NSE : NOVARTINDBSE : 500672ISIN CODE : INE234A01025Industry : TradingHouse : Novartis India - MNC
BSE1028.55-2.3 (-0.22 %)
PREV CLOSE ( ) 1030.85
OPEN PRICE ( ) 1030.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16324
TODAY'S LOW / HIGH ( )1026.00 1053.25
52 WK LOW / HIGH ( )559.7 1224
NSE672.250 (0 %)
PREV CLOSE( ) 672.25
OPEN PRICE ( ) 691.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 672.25 (249)
VOLUME 11837
TODAY'S LOW / HIGH( ) 668.35 698.20
52 WK LOW / HIGH ( )558.6 909
ChairmanC Snook
Managing DirectorSanjay Murdeshwar
Company SecretaryNikhil Malpani
Non Executive Independent DirectorJai Hiremath
Sandra Martyres
Sanker Parameswaran
Whole Time DirectorShilpa Joshi
Incorporation Year : 13-12 1947

Registered Office :

Address : The Inspire B K C, 7th Floor,Bandra Kurla Complex,Bandra East Mumbai,
Maharashtra-400051 .

Phone : 022-50243000

Industry : Trading

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.